Comparative Study of Hydroxytyrosol Acetate and Hydroxytyrosol in Activating Phase II Enzymes

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Nuclear factor E2-related factor 2 (Nrf2) regulates cellular antioxidant defense mechanisms.
• Hydroxytyrosol (HT), an olive-derived compound, is known to activate Nrf2.
• The Nrf2-activating potential of hydroxytyrosol acetate (HTac), an HT derivative, is largely unexplored.

Purpose of the Study:

• To compare the efficacy of HT and HTac in activating the Nrf2 pathway.
• To investigate the protective effects of HT and HTac against oxidative stress in ARPE-19 cells.
• To elucidate the molecular mechanisms underlying HTac's effects on Nrf2.

Main Methods:

• ARPE-19 cells were pretreated with HT or HTac and challenged with t-butyl hydroperoxide.
• Cell viability, mitochondrial membrane potential, and redox homeostasis were assessed.
• Nrf2-regulated phase II enzyme expression was analyzed.
• RNA-Seq was performed to examine global gene expression changes.
• The PI3K/Akt pathway was investigated.

Main Results:

• Both HT and HTac protected ARPE-19 cells from oxidative damage, with HTac being more effective at a lower concentration.
• HTac demonstrated superior activation of Nrf2-regulated phase II enzymes compared to HT.
• RNA-Seq revealed distinct cellular responses to HTac and HT, indicating broader effects of HTac.
• The PI3K/Akt pathway was identified as crucial for HTac's beneficial effects.

Conclusions:

• HTac is a more potent Nrf2 activator than HT.
• HTac exhibits enhanced antioxidative capacity and triggers diverse cellular responses.
• HTac's ability to efficiently activate the Nrf2 system supports its therapeutic potential for diseases involving oxidative stress.